Does intensive blood-glucose lowering reduce the risk of cardiovascular disease in patients with type 2 diabetes

August 2008

Does intensive blood-glucose lowering reduce the risk of cardiovascular disease in patients with type 2 diabetes?

We know that lowering A1C decreases the risk of microvascular disease such as retinopathy and nephropathy.

So many experts hoped it would also improve MACROvascular outcomes such as heart attacks and strokes.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Does intensive blood-glucose lowering reduce the risk of cardiovascular disease in patients with type 2 diabetes
Antithrombotics Pradax (dabigatran etexilate) to compete with warfarin and heparins
Antithrombotics what to do about aspirin, clopidogrel, NSAIDs, and warfarin when patients need surgery
Infectious Diseases tendon injuries will be highlighted in a new "boxed warning" for all oral and IV quinolones (ciprofloxacin, etc)
Infectious Diseases easier for Canadians to get Bicillin L-A for syphilis
Dyslipidemia whether more CHILDREN should be treated for dyslipidemia
Aspirin whether they should take TWO aspirin daily
Dermatology how to manage bug bites and stings
Supplements There's confusion about the different oral iron products
Men's Health BOTH Avodart (dutasteride) and Flomax (tamsulosin) for benign prostatic hyperplasia (BPH)
Men's Health finasteride (Proscar) to PREVENT prostate cancer
Pediatrics Many infants get antireflux meds when they don't need them
Sports Medicine drugs athletes may be using to enhance performance